Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19
Mar 20, 2020 11:10 am | Larry Luxner
Even with the coronavirus pandemic ravaging Europe and much of the world, patient advocate Lucia Monaco, PhD, of Italy remains confident that the Paris-based nonprofit she chairs will see the approval of 1,000 new rare disease therapies by 2027. That group, the International Rare Diseases Research Consortium (IRDiRC) — launched in 2011 by the European Union […]
The post Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19 appeared first on SMA News Today.